Matthew Garrett - Chief Financial Officer of iRhythm Technologies, Inc.

Person placeholder

Matthew Garrett

Chief Financial Officer since 2013

Total compensation: $786,928
Age: 49

Matthew C. Garrett is the Chief Financial Officer of the Company., since January 2013. Mr. Garrett brings more than 20 years of leadership experience in finance, investor relations, business development, and operations to our company. From March 2010 until December 2012, he served as Chief Financial Officer of Navigenics, Inc., a provider of genetic testing for common health conditions, where he led all finance functions, strategic partnerships, and successfully facilitated the sale of the company to Life Technologies Corp. From October 2008 until March 2010, Mr. Garrett served as Director of Business Development at Corventis Inc., a health monitor applications company, where he was responsible for directing corporate operations and business collaborations related to the advancement and promotion of the company’s health monitor applications. From October 2006 until September 2008, Mr. Garrett served as Vice President of Finance, Chief Accounting Officer and Treasurer for Cogentus Pharmaceuticals Inc., a developer of prescription pharmaceutical products. Earlier in his career, Mr. Garrett served as Finance Director in Research & Development and, subsequently, Director of Strategic Marketing and Pricing at Affymetrix, Inc. Prior to Affymetrix, he held various finance roles at Guidant Corporation, a medical technology company focused on cardiac and vascular solutions. Mr. Garrett holds a B.A. in Finance from the University of Iowa, Iowa City and an M.B.A. from the Kelley School of Business, Indiana University Bloomington.

iRhythm Technologies, Inc. logo

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram monitoring products for patients at risk for arrhythmias in the United States. It offers ZIO Service, a platform that combines wearable biosensor with proprietary algorithms that distill data from heartbeats into clinically actionable information. The company was founded in 2006 and is headquartered in San Francisco, California.

  • iRhythm Technologies, Inc., 650 Townsend Street, San Francisco 94103, United States
  • 415-632-5700